Score Breakdown
Offering Ability
27
Cash Runway
95
Float Risk
25
Warrant Exposure
15
Convertible Debt
15
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 52%
💰 Capital Raise
model 73%
• Critical: only 0.3 months cash remaining
• Active ATM program with $4M remaining capacity
🔄 Reverse Split
model est. 45%
• 50-day avg $1.57 approaching $1 threshold
• Only 0 months cash — financial pressure
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$95.31M
Shares Outstanding46.13M
Float36.21M
Cash$205.0K
Debt$250.0K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 89.8% shares (2026Q1 vs prior)
29 institutional holders · 3.37M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
938.9K shares
#2
SUSQUEHANNA INTERNATIONAL GROUP, LLP
448.7K shares
#3
CM Management, LLC
400.0K shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.77M
Days to Cover8.5
% of Float7.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-03-31
xbrl
XBRL CONVERTIBLE
2024-12-31
424B5
ATM
2026-04-02
8-K
8K EVENT
2026-04-02
8-K
8K EVENT
2026-03-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual OSTX Dilution Snapshot
OS Therapies Incorporated (OSTX) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $3.5M.
- Stored outstanding warrants: 444,041.
- Recent SEC activity tracked for OSTX: 424B5 on 2026-04-02; 8-K on 2026-04-02; xbrl on 2026-03-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: